Search

everythinglearnresearchcommunity

for

Search:↓

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Finasteride can cause sexual problems and depression in young men.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Finasteride use can cause depression-like behavior in male rats.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.